Similar companies
| Company | Transaction Value | |
|---|---|---|
![]() |
PfizerPFE |
$680,000 |
![]() |
Johnson & JohnsonJNJ |
-$121M |
![]() |
Mind Medicine (MindMed)MNMD |
-$70M |
![]() |
ModernaMRNA |
-$38.9B |
![]() |
AbbVieABBV |
-$801M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Jung Cassie | Oct 15, 2025 | Sell | 67,575 | $7.01 | $470,000 |
| Kraus Carl N | Oct 15, 2025 | Sell | 20,272 | $7 | $140,000 |
| Boyd Peter E. | Oct 15, 2025 | Sell | 10,000 | $7 | $70,000 |
| Barber Daniel | Sep 26, 2025 | Sell | 91,343 | $6.0343 | $550,000 |
| Boyd Peter E. | Sep 26, 2025 | Sell | 10,000 | $6.3 | $63,000 |
| Barber Daniel | Sep 19, 2025 | Sell | 400 | $6 | $2,400 |
| Boyd Peter E. | Sep 5, 2025 | Sell | 15,000 | $5.3 | $80,000 |
| Jung Cassie | Sep 4, 2025 | Sell | 62,180 | $5 | $310,000 |
| Jung Cassie | Nov 26, 2024 | Sell | 44 | $4.865 | $210 |
| Schobel Alexander Mark | Mar 15, 2024 | Sell | 50,000 | $6 | $300,000 |
| Schobel Alexander Mark | Mar 8, 2024 | Sell | 25,000 | $5.1874 | $130,000 |
What's the latest insider transaction for Aquestive Therapeutics?
The most recent insider transaction for Aquestive Therapeutics was conducted by Jung Cassie, who sold 67,575 shares on October 15, 2025 at a price of $7.01 per share.
Which insider has sold the most AQST stock over the last two years?
Jung Cassie has sold the most AQST stock in the last 2 years, with a total value of $780,000.
What is the total value of insider transactions for Aquestive Therapeutics (AQST) in the last 2 years?
The total value of insider transactions for Aquestive Therapeutics in the last 2 years is negative, amounting to -$2.1M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Aquestive Therapeutics' market confidence?
Over the last 2 years, insider transactions for Aquestive Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.






